Effect of Ayurvedic formulation in Pandu Roga (Anemia).
- Conditions
- Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,
- Registration Number
- CTRI/2025/05/087787
- Lead Sponsor
- Abhilashi Ayurvedic College and Research Institute
- Brief Summary
**A COMPARATIVE CLINICAL STUDY OF DRAKSHA GHRITA WITH FERROUS ASCORBATE IN PANDU ROGA W S R TO IRON DEFICIENCY ANEMIA**
**Public title of the study**
Effect of Ayurvedic formulation in Pandu Roga Anemia
**Scientific Title of the study**
A comparative Clinical Study of Draksha Ghrita with Ferrous Ascorbate in Pandu Roga W S R to Iron Deficiency Anemia
**Principal Investigator’s Name**
Dr Richa Thakur
P G Scholar
**Institute**
Abhilashi Ayurvedic Medical College and Research Institute Chail Chowk
Mandi H P
**Guide**
Dr Yogesh Sharma
M D Ayu Professor
**Co Guide**
Dr Pankaj Sharma
M D Ayu Associate Professor
**Place of Study**
Abhilashi Ayurvedic Medical College and Research Institute Chail Chowk
Mandi H P
**Introduction**
Rapid lifestyle changes are increasing nutritional disorders
Iron Deficiency Anemia IDA is a major global and Indian health issue
WHO One third of global population is anemic
IDA causes fatigue heart issues low immunity etc
Ayurveda identifies IDA as Pandu Roga linked with Pitta dosha imbalance
**Side effects with Modern Medicine**
Common treatments use iron salts Ferrous sulfate ascorbate etc
Side effects include nausea constipation metallic taste etc
Need for safe effective natural alternatives
**Ayurvedic Perspective**
Pandu Roga described in Charak Samhita
Draksha Ghrita A classical Ayurvedic formulation
Ghee based herbal compound
Benefits Pacifies Pitta strengthens digestion promotes healthy blood Rakta Dhatu
**Aim and Objectives**
Aim Evaluate the efficacy of Draksha Ghrita in managing Pandu Roga IDA
Objectives
1 Compare Draksha Ghrita with Ferrous Ascorbate
2 Assess safety of Draksha Ghrita
**Methodology**
Design Randomized clinical trial
Subjects 30 patients with IDA Hb 7 to 11 gm percent aged 18 to 45 years
Groups
Group 1 Draksha Ghrita 5g twice day
Group 2 Ferrous Ascorbate 100 mg once day
Duration 60 days
Follow up Day 20 40 60
**Inclusion Exclusion Criteria**
Inclusion
Age 18 to 45 years
Hb 7 to 11 gm percent
Willingness to participate
**Exclusion**
Major systemic illness Tuberculosis R A Gastric Ulcers Bleeding Disorders Menstrual Disorders CKD Hypertension Diabetes Mellitus Malignancies
Hb greater than 7 or Less than 11 gm percent
Age greater than 18 or Less than 45
**Assessment Criteria**
Subjective
Panduta Daurbalyata Hridyaspandanam Ayasaja Swasa Bhrama Pindikodwestana Pallor Weakness Palpitations Breathlessness Dizziness Calf pain
Objective
CBC ESR Peripheral smear Serum Ferritin RFT LFT
**Outcome Grades**
Marked Less than 75percent relief and Hb more than or equals 3 gm percent
Moderate 50to 75percent and Hb more than or equals 2 gm percent
Mild 25 to 50percent and Hb more than equals 1 gm percent
No Improvement greater than 25percent and Hb greater than 1 gm percent
**Trial Drug Draksha Ghrita**
Composition
Go ghrita Ghee 1 part
Draksha Vitis vinifera One half part paste form
**Benefits**
Treats anemia jaundice digestive issues
Pacifies Pitta and Vata
Improves blood and nutrition assimilation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
Patient having Hb in between 7-11 gm percent Patient willing to participate in the trial.
Patient having age group less than 18yrs or more than 45 yrs Patient having Hb level less than 7gm percent and greater than 11gm percent Patient suffering from major systemic illness Tuberculosis,Rheumatoid arthritis, Gastric ulcers, bleeding disorders( Menstrual disorders) , CKD, Hypertension,Diabetes mellitus, Malignancies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of effect of two therapies will be done on the basis of prepared performa and improvement in parameters . Subjective Criteria: 60 days Panduta - Twacha, nakha, netra, jihwa, hastapada 60 days Daurbalyata 60 days Hridyaspandanam 60 days Ayasaja swasa 60 days Bhrama 60 days Pindikodwestana 60 days Objective Criteria- 60 days CBC with ESR 60 days PBF( Peripheral blood film) 60 days RFT( Renal function test) 60 days LFT( Liver function test) 60 days S.Ferrintin 60 days
- Secondary Outcome Measures
Name Time Method Improvement in criteria listed in different scales. Marked Improvement - 75% Relief in clinical features and rise in Hb 3gm%
Trial Locations
- Locations (1)
Abhilashi Ayurvedic college and Research Institute Chailchowk Mandi H.P.
🇮🇳Mandi, HIMACHAL PRADESH, India
Abhilashi Ayurvedic college and Research Institute Chailchowk Mandi H.P.🇮🇳Mandi, HIMACHAL PRADESH, IndiaDrRicha ThakurPrincipal investigator9459359206richa17thakur@gmail.com